Chilton WS, Bigwood J, Jensen RE (1979). "Psilocin, bufotenine and serotonin: historical and biosynthetic observations". J Psychedelic Drugs11 (1–2): 61–9. PMID392119. doi:10.1080/02791072.1979.10472093.
Hoshino, Toshio; Shimodaira, Kenya (1935). "Synthese des Bufotenins und über 3-Methyl-3-β-oxyäthyl-indolenin. Synthesen in der Indol-Gruppe. XIV". Justus Liebig's Annalen der Chemie520 (1): 19–30. doi:10.1002/jlac.19355200104.
Davis W, Weil A (1992). "Identity of a New World Psychoactive Toad". Ancient Mesoamerica3: 51–9. doi:10.1017/s0956536100002297.
Pochettino, M. L.; Cortella, A. R.; Ruiz, M. (1999). "Hallucinogenic Snuff from Northwestern Argentina: Microscopical Identification of Anadenanthera colubrina var. cebil (Fabaceae) in Powdered Archaeological Material". Economic Botany53 (2): 127–132. ISSN0013-0001. JSTOR4256172. doi:10.1007/BF02866491.
Moretti C, Gaillard Y, Grenand P, Bévalot F, Prévosto JM (2006). "Identification of 5-hydroxy-tryptamine (bufotenine) in takini (Brosimumacutifolium Huber subsp. acutifolium C.C. Berg, Moraceae), a shamanic potion used in the Guiana Plateau". J Ethnopharmacol106 (2): 198–202. PMID16455218. doi:10.1016/j.jep.2005.12.022.
Siegel M (October 1965). "A sensitive method for the detection of n,n-dimethylserotonin (bufotenin) in urine; failure to demonstrate its presence in the urine of schizophrenic and normal subjects". J Psychiatr Res3 (3): 205–11. PMID5860629. doi:10.1016/0022-3956(65)90030-0.
Pomilio AB, Vitale AA, Ciprian-Ollivier J, Cetkovich-Bakmas M, Gómez R, Vázquez G (1999). "Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia". J Ethnopharmacol65 (1): 29–51. PMID10350367. doi:10.1016/S0378-8741(98)00163-9.
Takeda N, Ikeda R, Ohba K, Kondo M (November 1995). "Bufotenine reconsidered as a diagnostic indicator of psychiatric disorders". NeuroReport6 (17): 2378–80. PMID8747157. doi:10.1097/00001756-199511270-00024.
Takeda N (February 1994). "Serotonin-degradative pathways in the toad (Bufo bufo japonicus) brain: clues to the pharmacological analysis of human psychiatric disorders". Comp Biochem Physiol Pharmacol Toxicol Endocrinol107 (2): 275–81. PMID7749594. doi:10.1016/1367-8280(94)90051-5.
Pochettino, M. L.; Cortella, A. R.; Ruiz, M. (1999). "Hallucinogenic Snuff from Northwestern Argentina: Microscopical Identification of Anadenanthera colubrina var. cebil (Fabaceae) in Powdered Archaeological Material". Economic Botany53 (2): 127–132. ISSN0013-0001. JSTOR4256172. doi:10.1007/BF02866491.
nih.gov
ncbi.nlm.nih.gov
Chilton WS, Bigwood J, Jensen RE (1979). "Psilocin, bufotenine and serotonin: historical and biosynthetic observations". J Psychedelic Drugs11 (1–2): 61–9. PMID392119. doi:10.1080/02791072.1979.10472093.
Moretti C, Gaillard Y, Grenand P, Bévalot F, Prévosto JM (2006). "Identification of 5-hydroxy-tryptamine (bufotenine) in takini (Brosimumacutifolium Huber subsp. acutifolium C.C. Berg, Moraceae), a shamanic potion used in the Guiana Plateau". J Ethnopharmacol106 (2): 198–202. PMID16455218. doi:10.1016/j.jep.2005.12.022.
Siegel M (October 1965). "A sensitive method for the detection of n,n-dimethylserotonin (bufotenin) in urine; failure to demonstrate its presence in the urine of schizophrenic and normal subjects". J Psychiatr Res3 (3): 205–11. PMID5860629. doi:10.1016/0022-3956(65)90030-0.
Pomilio AB, Vitale AA, Ciprian-Ollivier J, Cetkovich-Bakmas M, Gómez R, Vázquez G (1999). "Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia". J Ethnopharmacol65 (1): 29–51. PMID10350367. doi:10.1016/S0378-8741(98)00163-9.
Takeda N, Ikeda R, Ohba K, Kondo M (November 1995). "Bufotenine reconsidered as a diagnostic indicator of psychiatric disorders". NeuroReport6 (17): 2378–80. PMID8747157. doi:10.1097/00001756-199511270-00024.
Takeda N (February 1994). "Serotonin-degradative pathways in the toad (Bufo bufo japonicus) brain: clues to the pharmacological analysis of human psychiatric disorders". Comp Biochem Physiol Pharmacol Toxicol Endocrinol107 (2): 275–81. PMID7749594. doi:10.1016/1367-8280(94)90051-5.
Emanuele E, Colombo R, Martinelli V, Brondino N, Marini M, Boso M, Barale F, Politi P (2010). "Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia". Neuro Endocrinol Lett31 (1): 117–21. PMID20150873.
Pochettino, M. L.; Cortella, A. R.; Ruiz, M. (1999). "Hallucinogenic Snuff from Northwestern Argentina: Microscopical Identification of Anadenanthera colubrina var. cebil (Fabaceae) in Powdered Archaeological Material". Economic Botany53 (2): 127–132. ISSN0013-0001. JSTOR4256172. doi:10.1007/BF02866491.